Elodie Creton

Parc Club Orsay Université
Orsay, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse immunosuppressive profiles.

A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse immunosuppressive profiles.

Journal: Frontiers in immunology

Published: October 29, 2025

Role of amino acid 159 in carbapenem and temocillin hydrolysis of OXA-933, a novel OXA-48 variant.

Role of amino acid 159 in carbapenem and temocillin hydrolysis of OXA-933, a novel OXA-48 variant.

Journal: Antimicrobial agents and chemotherapy

Published: March 25, 2024

Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.

Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.

Journal: The Journal of antimicrobial chemotherapy

Published: January 10, 2024

Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study.

Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study.

Journal: The Lancet. Microbe

Published: January 17, 2023

Polyclonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae, France, 2013-2021.

Polyclonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae, France, 2013-2021.

Journal: Emerging infectious diseases

Published: October 26, 2022

Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam.

Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam.

Journal: International journal of antimicrobial agents

Published: May 23, 2022

Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response.

Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response.

Journal: The Journal of antimicrobial chemotherapy

Published: February 24, 2022

Activity of mecillinam against carbapenem-resistant Enterobacterales.

Activity of mecillinam against carbapenem-resistant Enterobacterales.

Journal: The Journal of antimicrobial chemotherapy

Published: February 22, 2022

Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.

Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.

Journal: The Journal of antimicrobial chemotherapy

Published: March 08, 2021

Polyclonal Dissemination of NDM-1- and NDM-9-Producing Escherichia coli and Klebsiella pneumoniae in French Polynesia.

Polyclonal Dissemination of NDM-1- and NDM-9-Producing Escherichia coli and Klebsiella pneumoniae in French Polynesia.

Journal: Antimicrobial agents and chemotherapy

Published: November 19, 2020

Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii.

Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii.

Journal: International journal of antimicrobial agents

Published: June 05, 2020

Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs.

Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs.

Journal: The Journal of molecular diagnostics : JMD

Published: May 21, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026